Amygdala Neurosciences, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2015-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.amygns.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study to Evaluate the Safety of the Coadministration of ANS-6637 and Ethanol
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- Drug: ANS-6637 Oral TabletDrug: Placebo Oral Tablet
- First Posted Date
- 2017-06-29
- Last Posted Date
- 2018-01-17
- Lead Sponsor
- Amygdala Neurosciences, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT03203499
- Locations
- 🇺🇸
Vince and Associates, Overland Park, Kansas, United States
News
No news found